Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Dogma in Doubt: Hydrolysis of Equatorial Ligands of Pt IV Complexes under Physiological Conditions
Alexander Kastner, Isabella Poetsch, Josef Mayr, et al.
Angewandte Chemie International Edition (2019) Vol. 58, Iss. 22, pp. 7464-7469
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Metallodrugs in cancer nanomedicine
Quim Peña, Alec Wang, Orysia Zaremba, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 7, pp. 2544-2582
Closed Access | Times Cited: 144
Recent advances in the synthesis, stability, and activation of platinum(IV) anticancer prodrugs
Zoufeng Xu, Zhigang Wang, Zhiqin Deng, et al.
Coordination Chemistry Reviews (2021) Vol. 442, pp. 213991-213991
Closed Access | Times Cited: 123
Oxaliplatin and its derivatives – An overview
Paul O'Dowd, Darragh F. Sutcliffe, Darren M. Griffith
Coordination Chemistry Reviews (2023) Vol. 497, pp. 215439-215439
Open Access | Times Cited: 33
Platinum-based drugs in cancer treatment: Expanding horizons and overcoming resistance
Mona Shahlaei, Shaahin Mohammadzadeh Asl, Atefe Derakhshani, et al.
Journal of Molecular Structure (2023) Vol. 1301, pp. 137366-137366
Closed Access | Times Cited: 25
Recent updates in nanoscale delivery systems of platinum(IV) antitumor prodrugs
Zhiyuan Zhou, Pengmin Shi, Changli Wang, et al.
Coordination Chemistry Reviews (2024) Vol. 508, pp. 215774-215774
Closed Access | Times Cited: 13
Pt(iv) antitumor prodrugs: dogmas, paradigms, and realities
Mauro Ravera, Elisabetta Gabano, Michael J. McGlinchey, et al.
Dalton Transactions (2021) Vol. 51, Iss. 6, pp. 2121-2134
Closed Access | Times Cited: 46
Flavin-Conjugated Pt(IV) Anticancer Agents
Juan Sánchez-Camacho, Sonia Infante-Tadeo, Ana C. Carrasco, et al.
Inorganic Chemistry (2023) Vol. 62, Iss. 14, pp. 5644-5651
Open Access | Times Cited: 22
Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands
Pavel Štarha, Radka Křikavová
Coordination Chemistry Reviews (2023) Vol. 501, pp. 215578-215578
Closed Access | Times Cited: 22
Tumor-targeted dual-action NSAID-platinum(iv) anticancer prodrugs
Alexander Kastner, Theresa Mendrina, Florian Bachmann, et al.
Inorganic Chemistry Frontiers (2023) Vol. 10, Iss. 14, pp. 4126-4138
Open Access | Times Cited: 21
Multitargeted Platinum(IV) Anticancer Complexes Bearing Pyridinyl Ligands as Axial Leaving Groups
Qiyuan Zhou, Shu Chen, Zoufeng Xu, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 18
Closed Access | Times Cited: 18
Pt(iv) anticancer prodrugs bearing an oxaliplatin scaffold: what do we know about their bioactivity?
Alvaro Lopez-Sanchez, Hélène Bertrand
Inorganic Chemistry Frontiers (2024) Vol. 11, Iss. 6, pp. 1639-1667
Closed Access | Times Cited: 7
Enhancing Pt(IV) Complexes' Anticancer Activity upon Encapsulation in Stimuli‐Responsive Nanocages
María Sancho‐Albero, Giorgio Facchetti, Nicolò Panini, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 17
Open Access | Times Cited: 15
Applications of Biodegradable Polymers in the Encapsulation of Anticancer Metal Complexes
Marta Redrado, Zhimei Xiao, Kanokon Upitak, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 36
Open Access | Times Cited: 5
Anticancer platinum agents and light
Juan Gurruchaga‐Pereda, Álvaro Martínez, Alessio Terenzi, et al.
Inorganica Chimica Acta (2019) Vol. 495, pp. 118981-118981
Open Access | Times Cited: 36
Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor Agents: Minimal Structural Variations and Great Performance Changes
Alfonso Annunziata, Angela Amoresano, Maria Elena Cucciolito, et al.
Inorganic Chemistry (2020) Vol. 59, Iss. 6, pp. 4002-4014
Open Access | Times Cited: 36
Insertion of (Bioactive) Equatorial Ligands into Platinum(IV) Complexes
Alexander Kastner, Hemma Schueffl, Patrick A. Yassemipour, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 46
Open Access | Times Cited: 11
Light-Responsive Pt(IV) Prodrugs with Controlled Photoactivation and Low Dark Toxicity
Daniil Spector, Anna Bubley, A. Zharova, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 5, pp. 3431-3440
Closed Access | Times Cited: 4
Photosubstitution and photoreduction of a diazido platinum(iv) anticancer complex
Huayun Shi, Christian Ward-Deitrich, Fortuna Ponte, et al.
Dalton Transactions (2024) Vol. 53, Iss. 31, pp. 13044-13054
Open Access | Times Cited: 4
A new fluorescent oxaliplatin(iv) complex with EGFR-inhibiting properties for the treatment of drug-resistant cancer cells
Monika Caban, Philipp Fronik, Alessio Terenzi, et al.
Inorganic Chemistry Frontiers (2025)
Open Access
Novel platinum(IV) prodrugs with tetraacetylriboflavin axial ligand possessing enhanced light-induced toxicity
Daniil Viktorovich Spector, Roman Akasov, Dmitrii M. Mazur, et al.
Mendeleev Communications (2025) Vol. 35, Iss. 3, pp. 282-284
Closed Access
Fluoxetine-Conjugated Platinum(IV) Prodrugs Targeting eEF2K and Conquering Multidrug Resistance against Triple-Negative Breast Cancer
Jia-Qian Wang, Xiaomeng Liu, Zhiguo Zhu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Research progress of azido-containing Pt(IV) antitumor compounds
Meilin Mu, Jiuyu Zhan, Xiaohan Dai, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113927-113927
Closed Access | Times Cited: 26
Platinum (IV) drugs with cannabidiol inducing mitochondrial dysfunction and synergistically enhancing anti-tumor effects
Tangli Wei, Lihua Chen, Pengmin Shi, et al.
Journal of Inorganic Biochemistry (2024) Vol. 254, pp. 112515-112515
Closed Access | Times Cited: 3
Pt(IV) Anticancer Prodrugs – A Tale of Mice and Men
Dan Gibson
ChemMedChem (2021) Vol. 16, Iss. 14, pp. 2188-2191
Closed Access | Times Cited: 21
Page 1 - Next Page

Scroll to top